Figure 4From: Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors Cost-effectiveness acceptability curves for the decision concerning the most efficient management of OA at the Instituto Mexicano del Seguro Social. Back to article page